Medicenna Therapeutics Corp Stock Price Prediction
| MDNA Stock | CAD 1.77 0.10 5.99% |
Oversold Vs Overbought
31
Oversold | Overbought |
EPS Estimate Next Quarter (0.06) | EPS Estimate Current Year (0.21) | EPS Estimate Next Year (0.24) | Wall Street Target Price 5 |
Using Medicenna Therapeutics hype-based prediction, you can estimate the value of Medicenna Therapeutics Corp from the perspective of Medicenna Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medicenna Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Medicenna because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Medicenna Therapeutics after-hype prediction price | CAD 1.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medicenna |
Medicenna Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Medicenna Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medicenna Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medicenna Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Medicenna Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Medicenna Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medicenna Therapeutics' historical news coverage. Medicenna Therapeutics' after-hype downside and upside margins for the prediction period are 0.09 and 7.14, respectively. We have considered Medicenna Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Medicenna Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Medicenna Therapeutics is based on 3 months time horizon.
Medicenna Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Medicenna Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medicenna Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medicenna Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 5.37 | 0.05 | 0.01 | 2 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.77 | 1.77 | 0.00 |
|
Medicenna Therapeutics Hype Timeline
Medicenna Therapeutics is now traded for 1.77on Toronto Exchange of Canada. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of 0.01. Medicenna is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at -0.19%. %. The volatility of related hype on Medicenna Therapeutics is about 13425.0%, with the expected price after the next announcement by competition of 1.78. About 22.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.38. Medicenna Therapeutics last dividend was issued on the 3rd of March 2017. The entity had 1:14 split on the 3rd of March 2017. Assuming the 90 days trading horizon the next estimated press release will be in a few days. Check out Medicenna Therapeutics Basic Forecasting Models to cross-verify your projections.Medicenna Therapeutics Related Hype Analysis
Having access to credible news sources related to Medicenna Therapeutics' direct competition is more important than ever and may enhance your ability to predict Medicenna Therapeutics' future price movements. Getting to know how Medicenna Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medicenna Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| APS | Aptose Biosciences | 0.03 | 2 per month | 0.00 | (0.21) | 5.66 | (9.62) | 34.00 | |
| ONC | Oncolytics Biotech | 0.06 | 2 per month | 3.07 | (0) | 6.47 | (5.16) | 37.61 | |
| HBP | Helix BioPharma Corp | 0.03 | 2 per month | 0.00 | (0.05) | 9.35 | (10.62) | 46.60 |
Medicenna Therapeutics Additional Predictive Modules
Most predictive techniques to examine Medicenna price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medicenna using various technical indicators. When you analyze Medicenna charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Medicenna Therapeutics Predictive Indicators
The successful prediction of Medicenna Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medicenna Therapeutics Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medicenna Therapeutics based on analysis of Medicenna Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medicenna Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medicenna Therapeutics's related companies. | 2021 | 2022 | 2024 (projected) | Net Debt To EBITDA | 0.91 | 2.06 | 1.61 | Intangibles To Total Assets | 0.002771 | 0.001674 | 0.00283 |
Story Coverage note for Medicenna Therapeutics
The number of cover stories for Medicenna Therapeutics depends on current market conditions and Medicenna Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medicenna Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medicenna Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Medicenna Therapeutics Short Properties
Medicenna Therapeutics' future price predictability will typically decrease when Medicenna Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Medicenna Therapeutics Corp often depends not only on the future outlook of the potential Medicenna Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medicenna Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 69.6 M | |
| Cash And Short Term Investments | 17 M |
Other Information on Investing in Medicenna Stock
Medicenna Therapeutics financial ratios help investors to determine whether Medicenna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicenna with respect to the benefits of owning Medicenna Therapeutics security.